Life Saving Drugs Program resources – Infantile-onset LAL-D – Sebelipase alfa (Kanuma)

This collection contains guidelines, forms and documents related to accessing sebelipase alfa under the Life Saving Drugs Program.

View the product information for Sebelipase alfa (Kanuma®)  on the Therapeutic Goods Administration website.



We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.